5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | NEUTRAL | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | N/A | N/A | N/A | 301.91▼ | 298.36▲ |
MA10 | N/A | N/A | N/A | 299.42▲ | 301.82▼ |
MA20 | N/A | N/A | N/A | 297.56▲ | 299.45▲ |
MA50 | N/A | N/A | N/A | 302.13▼ | 317.99▼ |
MA100 | N/A | N/A | N/A | 302.53▼ | 300.42▼ |
MA200 | N/A | N/A | N/A | 317.85▼ | 272.18▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | 0.833▲ | 1.022▲ |
RSI | N/A | N/A | N/A | 51.061▲ | 46.835▼ |
STOCH | N/A | N/A | N/A | 74.157 | 47.707 |
WILL %R | N/A | N/A | N/A | -41.433 | -34.874 |
CCI | N/A | N/A | N/A | 67.746 | 27.102 |
Wednesday, April 30, 2025 06:36 AM
GSK (LSE:GSK) reported a significant improvement in its first-quarter earnings, with sales, net income, and earnings per share all showing promising growth. This announcement coincided with a 5.14 ...
|
Friday, March 28, 2025 09:25 AM
Assa Abloy AB Series B annual cash flow and in depth look at 0R87.UK operating, investing, and financing activities.
|
Thursday, February 06, 2025 05:40 PM
In a report released on February 5, Johan Sjoberg from Kepler Capital maintained a Buy rating on Assa Abloy (0R87 – Research Report), with a price target of SEK375.00. The company’s shares ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
14/07/25 | 300.40 | 302.25 | 300.40 | 300.40 | 4,647 |
11/07/25 | 305.40 | 305.40 | 302.65 | 302.65 | 6,803 |
10/07/25 | 301.90 | 307.05 | 301.90 | 304.95 | 425,958 |
09/07/25 | 301.30 | 303.20 | 301.30 | 303.20 | 5,980 |
08/07/25 | 298.60 | 299.00 | 295.40 | 298.35 | 8,782 |
07/07/25 | 296.45 | 298.25 | 296.00 | 296.45 | 5,983 |
04/07/25 | 296.05 | 296.25 | 294.10 | 296.25 | 720 |
03/07/25 | 299.60 | 300.10 | 297.60 | 299.25 | 4,207 |
02/07/25 | 297.40 | 299.20 | 296.20 | 297.40 | 36,880 |
01/07/25 | 295.25 | 295.25 | 292.40 | 295.25 | 3,502 |
|
|
||||
|
|
||||
|
|